US Patent 9,890,141 — assignment history and current owner

US 9,890,141 · Application 15/144,892

Crystalline Pharmaceutical And Methods Of Preparation And Use Thereof

Who owns US Patent 9,890,141?

US9890141 ("Crystalline Pharmaceutical And Methods Of Preparation And Use Thereof") — current assignee: BAUSCH + LOMB IRELAND LIMITED. Status: Active, estimated expiration October 21, 2030. 8 recorded USPTO assignments.

Based on recorded USPTO assignment data, the apparent operating assignee of US Patent 9,890,141 is BAUSCH + LOMB IRELAND LIMITED. Based on the most recent ownership transfer record (recorded 2023-12-06).

Patent title
Crystalline Pharmaceutical And Methods Of Preparation And Use Thereof
Application number
15/144,892
Apparent operating assignee
BAUSCH + LOMB IRELAND LIMITED
Patent status
Active, estimated expiration October 21, 2030
Recorded assignments
8

Note: security interests appear active (JPMORGAN CHASE BANK, N.A., AS COLLATERAL AGENT; CITIBANK, N.A., AS NOTES COLLATERAL AGENT) with no recorded release. Security interests reflect financing arrangements, not operating ownership.

Recorded assignment history

ExecutedRecordedConveyanceAssignor(s)Assignee(s)Reel/frame
Dec 14, 2010May 2, 2017Ownership TransferBURNIER, JOHNSARCODE CORPORATION42208/520
Jul 15, 2011May 2, 2017Name ChangeSARCODE CORPORATIONSARCODE BIOSCIENCE INC.42385/46
Jul 1, 2019Oct 31, 2019Ownership TransferSARCODE BIOSCIENCE INC.NOVARTIS AG50900/268
Oct 21, 2020Oct 22, 2020Ownership TransferNOVARTIS AGNOVARTIS PHARMACEUTICALS CORPORATION54134/708
Sep 29, 2023Dec 6, 2023Ownership TransferNOVARTIS PHARMACEUTICALS CORPORATIONBAUSCH + LOMB IRELAND LIMITED65789/853
Dec 18, 2025Dec 23, 2025Security AgreementBAUSCH + LOMB IRELAND LIMITEDJPMORGAN CHASE BANK, N.A., AS COLLATERAL AGENT74050/573
Dec 18, 2025Dec 23, 2025Security AgreementBAUSCH + LOMB IRELAND LIMITEDCITIBANK, N.A., AS NOTES COLLATERAL AGENT74050/682
Dec 18, 2025Dec 23, 2025Security AgreementBAUSCH + LOMB IRELAND LIMITEDCITIBANK, N.A., AS NOTES COLLATERAL AGENT74050/709

Scrolls sideways on narrow screens

Chain of title

In 2017, BURNIER, JOHN assigned the patent to SARCODE CORPORATION. The most recent ownership transfer, recorded in 2023, lists BAUSCH + LOMB IRELAND LIMITED as assignee. In 2017, SARCODE CORPORATION changed its name to SARCODE BIOSCIENCE INC.. In 2025, JPMORGAN CHASE BANK, N.A., AS COLLATERAL AGENT recorded a security interest; this reflects a financing arrangement, not a change in operating ownership.

Apparent recorded rights summary — disclaimer

This tool presents recorded assignment data from the USPTO assignment database. It does not constitute a legal opinion on ownership or title. Assignments may exist that have not been recorded. Corrective records, off-record transfers, court orders, and other events may affect actual ownership. Consult a qualified patent attorney for definitive title analysis.

Ownership settled? Give your AI the file.

Application 15/144,892 · US 9,890,141

The recorded chain of title is one part of the record. PatentReply compiles the rest of US 9,890,141, from the claims as filed to the last action, for Claude, ChatGPT, Grok, or another supported AI client.

One new published application a month is free. The first compile takes a few minutes.

Strategy and filing changes require your approval.

How PatentReply handles an Office Action response →

Data sourced from public USPTO assignment records. This tool provides informational summaries and should not be relied upon as legal advice or a definitive title opinion. Always verify patent ownership independently, especially where unrecorded transfers, court orders, or other off-record events may apply.